Literature DB >> 17895029

Effect of nicardipine on cerebral blood flow in hypertensive patients with internal carotid artery occlusion: a PET study.

Y Nagahama1, H Fukuyama, H Yamauchi, Y Katsumi, Y Dong, J Konishi, J Kimura.   

Abstract

PURPOSE: The objective of this study was to elucidate the effect of intravenous administration of nicardipine on the cerebral blood flow of hypertensive patients with internal carotid artery occlusion (ICAO). PATIENTS AND METHODS: Six patients with ICAO and 10 normal individuals were examined by positron emission tomography. The cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral metabolic rate of oxygen, oxygen extraction fraction (OEF) and CBF/CBV ratio were evaluated for each vascular territory and each hemisphere, and the interhemispheric asymmetry index of each parameter was also calculated. Nicardipine was administered intravenously to each patient, and the changes in CBF (DeltaCBF%) and in blood pressure (DeltaBP) were examined.
RESULTS: After the administration of nicardipine, the CBF was significantly increased in the patient hemisphere and was unchanged in the occluded hemisphere. Stepwise regression analysis disclosed that the DeltaBP and asymmetry index of OEF were significantly correlated with the DeltaCBF% in the occluded hemisphere.
CONCLUSIONS: These results suggest that CBF is unchanged or increased in ICAO patients after nicardipine administration, but that excessive reduction of blood pressure may lead to CBF decrease in the patients with marked hemodynamic imbalance between the occluded and patent hemispheres. These results suggest that it is advisable not to reduce blood pressure excessively in these patients in the treatment of perioperative or acute hypertension with calcium antagonist.

Entities:  

Year:  1997        PMID: 17895029     DOI: 10.1016/s1052-3057(97)80214-5

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  4 in total

1.  Long-term hemodynamic changes and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Tatsuya Higashi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-18       Impact factor: 6.200

Review 2.  Evidence for Cerebral Hemodynamic Measurement-based Therapy in Symptomatic Major Cerebral Artery Disease.

Authors:  Hiroshi Yamauchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-06-02       Impact factor: 1.742

3.  Selective neuronal damage and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Kuninori Kusano; Chio Okuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-05-24       Impact factor: 10.154

4.  Impaired perfusion modifies the relationship between blood pressure and stroke risk in major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Tatsuya Higashi; Shinya Kagawa; Yoshihiko Kishibe; Masaaki Takahashi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.